Surgery Partners
SGRY
92 hedge funds and large institutions have $287M invested in Surgery Partners in 2016 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 11 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 25
55% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 11
37.35% more ownership
Funds ownership: 0% → 37.35% (+37%)
7% more funds holding
Funds holding: 86 → 92 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less capital invested
Capital invested by funds: $362M → $287M (-$74.8M)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.9M |
| 2 |
ClearBridge Investments
New York
|
+$7.91M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$5.12M |
| 4 |
JP Morgan Chase
New York
|
+$4.1M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$3.26M |
Top Sellers
SGRY Hedge Fund Activity: Q4 2016 in Review
92 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q4 2016, worth a combined $287M — down 21% from $362M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new SGRY positions and 11 closed out — a net gain of 6 holders — while 39 added to existing stakes and 25 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $10.9M. The largest seller was Vaughan Nelson Investment Management, cutting an estimated $23.3M.
- 92 institutional investors held Surgery Partners (SGRY) as of Q4 2016, up from 86 in Q3 2016.
- Funds reported $287M of Surgery Partners stock for Q4 2016, down 21% quarter-over-quarter.
- 17 funds opened new Surgery Partners positions in Q4 2016 and 11 closed out, a net change of +6 holders.
- The largest Surgery Partners buyer in Q4 2016 was Fidelity Investments, an estimated $10.9M added.
- The largest Surgery Partners seller in Q4 2016 was Vaughan Nelson Investment Management, an estimated $23.3M sold.
Based on aggregated 13F filings for Q4 2016.